C50.62
Malignant neoplasm of axillary tail of breast, male
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the axillary tail of the breast, specifically in males, refers to a type of breast cancer that originates in the tissue located in the axillary tail—a small extension of breast tissue that reaches into the armpit area. Although breast cancer is more common among women, males can also develop this disease. The diagnosis, treatment options, and understanding of this condition are essential for effective management and care.
Causes & Symptoms
Clinical Causes: Genetic mutations, such as BRCA1 and BRCA2 gene mutations Family history of breast cancer Hormonal factors, including prolonged exposure to estrogen Radiation exposure to the chest area Ageing, with higher risk as age increases Environmental factors and lifestyle choices, such as smoking and alcohol use Previous history of breast diseases or prior chest radiation
Key Symptoms: Lump or mass in the breast or underarm area Changes in the size or shape of the breast Skin alterations on the breast, such as redness or puckering Nipple discharge, which may be clear or bloody Pain or tenderness in the breast or armpit Swelling or redness in the breast tissue
Diagnostic & Treatment
Diagnosis Path: Clinical breast examination focusing on the breast and axillary region Imaging studies such as mammography and ultrasound to visualize the tumor Biopsy procedures, including fine-needle aspiration or core biopsy, to confirm malignancy and determine the cancer type Hormone receptor testing to assess if the cancer responds to hormonal therapies Additional scans like MRI or CT might be ordered to evaluate the extent of disease spread
Treatment Protocols: Surgical removal of the tumor, typically through lumpectomy or mastectomy, depending on the size and extent Lymph node assessment or removal to check for spread within the armpit region Radiation therapy to target residual cancer cells in the breast or surrounding areas Chemotherapy to destroy cancer cells systemically, especially if the disease has spread Hormonal therapy for cancers that are hormone receptor-positive, such as tamoxifen or aromatase inhibitors Targeted therapy aimed at specific cancer cell markers can be considered in certain cases Follow-up care including regular imaging and clinical exams to monitor for recurrence
Clinical Advice & FAQs
Billing Guidance
Is C50.62 a billable ICD-10 code?
Yes, C50.62 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.62?
Clinical documentation must specify the nature of Malignant neoplasm of axillary tail of breast, male and any associated comorbidities for accurate reporting.
Cite this Clinical Reference